The effects of the IFN-γ-blocking antibodies or of the knock-down of IFNGR1 were not a particularity of BT474 cells, similar effects were observed when assaying different HER2-positive cultures from breast cancer PDXs and an additional cell line (Supplementary Fig. 4a–i). Here, IFNGR1 is linked to breast cancer.